Hôpital Européen Marseille
Clinical trials sponsored by Hôpital Européen Marseille, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a simple exercise test tell ME/CFS apart from heart disease? Results expected Dec 2026 (estimated)
- Can a simple skin stimulation ease trauma after intensive care? Results expected Jun 2027 (estimated)
- COVID lung damage: who gets scarred? Results expected Jun 2027 (estimated)
-
Two-Minute sweat test could spot hidden nerve damage
Diagnosis CompletedThis study tested a device called SUDOSCAN, which measures sweat function in just two minutes, to see if it can detect small fiber nerve damage in people with autoimmune diseases (like lupus or rheumatoid arthritis) or unexplained pain. Researchers enrolled 139 adults and compare…
Sponsor: Hôpital Européen Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Can a simple glue stop Post-Surgery fluid pockets in breast cancer patients?
Symptom relief CompletedThis study tested whether a surgical glue called Ifabond can reduce seroma—painful fluid collections—after breast cancer surgery. 104 women having partial mastectomy with or without lymph node removal were randomly assigned to receive standard surgery plus the glue or standard su…
Sponsor: Hôpital Européen Marseille • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New french questionnaires aim to better diagnose dizziness and detachment disorders
Knowledge-focused CompletedThis study tested French versions of two questionnaires: one measures feelings of detachment from oneself (depersonalization), and the other helps diagnose a chronic dizziness condition called PPPD. Researchers enrolled 612 adults with and without balance disorders to ensure the …
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Gut bacteria differences found in IBD and Parkinson's patients
Knowledge-focused CompletedThis completed study examined gut bacteria in 15 people with inflammatory bowel disease (IBD) or Parkinson's disease, comparing them to healthy individuals. Researchers analyzed stool and blood samples to see if bacteria from the gut move into the bloodstream. The goal was to und…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:27 UTC